Literature DB >> 7536333

Primary carcinoma of the gall-bladder: potential for external radiation therapy.

M Mahe1, C Stampfli, P Romestaing, N Salerno, J P Gerard.   

Abstract

Nineteen patients (14 women, 5 men) received external radiation therapy (ERT) between 1980 and 1988 for gall-bladder carcinoma. Eleven patients had complete resection (cholecystectomy in eight cases), six incomplete gross resection and two only percutaneous transhepatic biliary drainage (PTBD). The modalities of ERT were variable and doses ranged from 30 Gy/10 fractions to 50 Gy/25 fractions. Among 11 patients with complete resection (9/11 with T1 or T2 stages), overall survival was 55% at 48 months and 36% at 60 months, median survival was 48 months and at the time of this report 3/11 patients were alive with no evidence of disease, 54, 65, 76 months after surgery, and eight dead of cancer 8-114 months. Local control was achieved in 66 patients with T1 or T2 stages. All eight patients who had palliative surgery or PTBD died of cancer after 4-20 months with median survival of 6 months. Three complications were noted: one gastric ulcer in the course of ERT (surgical treatment), one duodenal ulcer which occurred 6 months after completion of ERT (medical treatment) and one regressive radiation hepatitis. From this experience it appears that ERT in gall-bladder carcinoma is well tolerated, can obtain local control and prolonged survival after complete resection and good palliation in non-resectable tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7536333     DOI: 10.1016/0167-8140(94)90355-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.

Authors:  Hiroshi Itoh; Koji Nishijima; Yoshiyuki Kurosaka; Shigeru Takegawa; Masato Kiriyama; Shotaro Dohba; Yasuhiko Kojima; Yasuo Saitoh
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.

Authors:  Woo Seok Kim; Dong Wook Choi; Dong Do You; Chuan Yu Ho; Jin Seok Heo; Seong Ho Choi
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

Review 3.  Chemotherapy and targeted therapy for gall bladder cancer.

Authors:  Bhawna Sirohi; Ashish Singh; P Jagannath; Shailesh V Shrikhande
Journal:  Indian J Surg Oncol       Date:  2014-06-03

Review 4.  Current management of gallbladder carcinoma.

Authors:  Andrew X Zhu; Theodore S Hong; Aram F Hezel; David A Kooby
Journal:  Oncologist       Date:  2010-02-10

5.  Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy.

Authors:  Xiao-Nan Sun; Qi Wang; Ben-Xing Gu; Yan-Hong Zhu; Jian-Bin Hu; Guo-Zhi Shi; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

6.  Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.

Authors:  Edward Christopher Dee; Morgan E Freret; Nora Horick; Ann C Raldow; Lipika Goyal; Andrew X Zhu; Aparna R Parikh; David P Ryan; Jeffrey W Clark; Jill N Allen; Cristina R Ferrone; Carlos Fernandez-Del Castillo; Kenneth K Tanabe; Lorraine C Drapek; Theodore S Hong; Motaz Qadan; Jennifer Y Wo
Journal:  Ann Surg Oncol       Date:  2020-08-01       Impact factor: 5.344

7.  Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.

Authors:  Omar Hyder; Rebecca M Dodson; Teviah Sachs; Matthew Weiss; Skye C Mayo; Michael A Choti; Christopher L Wolfgang; Joseph M Herman; Timothy M Pawlik
Journal:  Surgery       Date:  2013-07-19       Impact factor: 3.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.